News
- Author:
- Neil Osterweil
Publish date: July 12, 2022
The experimental procedure could enable future widespread use of xenotransplantation to treat end-stage heart failure.
News
- Author:
- Neil Osterweil
Publish date: June 15, 2022
The dual interleukin-17 inhibitor was effective both in patients for whom TNF inhibitors failed and those who had never received a biologic disease...
News
- Author:
- Neil Osterweil
Publish date: June 10, 2022
The dual IL-17A and IL-17F inhibitor improved function, quality of life, and objective measures of inflammation, compared with placebo, in patients...
News
- Author:
- Neil Osterweil
Publish date: June 5, 2022
While there are similarities between some of the recommendations promulgated on each side of the Atlantic, there are significant differences and ev...
News
- Author:
- Neil Osterweil
Publish date: June 5, 2022
“Our data are reassuring as we saw no strong signal, which suggests that there is no need to switch the mother’s drugs.”
News
- Author:
- Neil Osterweil
Publish date: June 3, 2022
Artificial intelligence may improve early diagnosis of interstitial lung disease.
News
- Author:
- Neil Osterweil
Publish date: June 3, 2022
Despite steady declines in maternal and fetal mortality among pregnant women with systemic lupus erythematosus, maternal and fetal morbidities rema...
News
- Author:
- Neil Osterweil
Publish date: June 2, 2022
The JAK inhibitor was effective and safe for patients with rheumatologist-diagnosed axial spondyloarthritis that did not meet radiographic criteria...
News
- Author:
- Neil Osterweil
Publish date: May 20, 2022
Recent surveys show up to 80% of health care workers reporting burnout.
News
- Author:
- Neil Osterweil
Publish date: May 19, 2022
Nearly half of patients with severe, uncontrolled asthma who had a complete course of tezepelumab had a complete ...
News
- Author:
- Neil Osterweil
Publish date: May 18, 2022
Children in poor neighborhoods may be more likely to receive care in lower-quality hospitals or may be treated differently from other children when...
News
- Author:
- Neil Osterweil
Publish date: May 17, 2022
Adjusting for racial differences in lung-function measures appeared to miss emphysema in a significant proportion...
News
- Author:
- Neil Osterweil
Publish date: April 22, 2022
“It’s harder to understand why a presumably antibody-mediated side effect would be more likely to have that cross-reactivity where the tumor starte...
News
- Author:
- Neil Osterweil
Publish date: April 22, 2022
The combination resulted in significantly longer event-free survival.
News
- Author:
- Neil Osterweil
Publish date: April 22, 2022
The product, called lifileucel, is custom made for each patient.
